Biopharmaceutical and Pharmacodynamic Characteri-stics of Telmisartan Oral Disintegrating Films

DOI:

https://doi.org/10.37285/ijpsn.2019.12.2.6

Authors

  • Rajesh Kaza
  • Sujatha Kumari M
  • Kishore Babu M
  • Avinash A
  • Nagaraju R

Abstract



This research work was aimed to develop the telmisartan fast dissolving films. Fast dissolving films allow rapid drug dissolution in the oral cavity and thereby bypass the first pass metabolism. Solid dispersions of telmisartan using natural polymers such as hupu gum (HG), guar gum (GG) and xanthan gum (XG) were prepared by kneading technique and the optimized solid dispersion was exploited in the development of rapidly dissolving film. Telmisartan films were prepared by solvent casting method using different grades of HPMC (E5, 50 cps and K4M). Six formulations (FT1-FT6) of telmisartan films were prepared and evaluated for their physical characteristics such as thickness, tensile strength, percentage elongation, weight variation, folding endurance, drug content uniformity and surface pH and gave satisfactory results. The compatibility of the drug in the formulation was confirmed by FTIR and DSC studies. The formulations were subjected to disintegration, in vitro drug release and pharmacodynamic studies on spontaneous hypertensive rats (SHR). Amongst the formulations of FT1-FT6, FT6 was found as best formulation which contains HPMC E5 and telmisartan solid dispersion with guar gum at weight ratio of 1:2 and showed excellent film forming characteristics such as disintegration time at 42 sec and percentage drug release 97.98% within 10 minutes. The optimized film formulation (FT6) showed excellent stability over 45 days when stored at 40°C/60% RH. The pharmacodynamic study in SHR proved that fast dissolving films of telmisartan produced a faster onset of action.

   

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Fast dissolving films, First pass metabolism, Spontaneous hypertensive rats, Pharmacodynamic Studies, Solid dispersions, Telmisartan

Downloads

Published

2019-03-31

How to Cite

1.
Kaza R, M SK, M KB, A A, R N. Biopharmaceutical and Pharmacodynamic Characteri-stics of Telmisartan Oral Disintegrating Films. Scopus Indexed [Internet]. 2019 Mar. 31 [cited 2024 Nov. 22];12(2):4489-96. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/294

Issue

Vol. 12 No. 2 (2019): March-April 2019

Section

Research Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Badyal D.K, Lata H, and Dadhich AP (2003). Animal Models of Hypertension and Effect of Drugs. Indian j. of pharmacology, 35: 349-362.
Bhupinder B and Sarita J (2012). Formulation and evaluation of fast dissolving sublingual films of Rizatriptan Benzoate. Int. J. Drug Dev. & Res, 4(1): 133-143.
Dixit R and Puthli S (2009). Oral strip technology: Overview and future potential. Journal of controlled release, 139: 94-107.
Francesco Cilurzo, Irma E. Cupone, Paola Minghetti, Francesca Selmin, and Luisa Montanari (2008). Fast dissolving films made of maltodextrins. European Journal of pharmaceutics and Biopharmaceutics, 70(3): 895-900.
Kumar GV, Krishna RV, William GJ, and Konde A (2005). Formulation and evaluation of buccal films of salbutamol sulphate. Indian J Pharm Sci, 67(2): 160-164.
Kunte S and Tandale P (2010). Fast dissolving strips: a novel approach for the delivery of verapamil. Journal of pharmacy and bioallied sciences, 2(4): 325.
Marina K, Charyulu RN and Prabhakara P (2010). Mucoadhesive films of losartan potassium for buccal delivery: Design and Characterization. Indain J. Pharm. Educ. Res, 44(4): 315-323.
Mashru RC, Sutariya VB, Sankalia MG and Parikh PP (2005). Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm, 31(1): 25-34.
Mishra R and Amin A (2009). Formulation development of Taste-Masked Rapidly Dissolving Films of Cetirizine Hydrochloride. Pharma. Tech., 33(2): 48-56.
Monica R, Amrita B, Ishwar K, Ghanshyam M and Francesco T (2012). In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan. J Incl Phenom Macrocycl Chem. DOI 10.1007/s10847-012-0224-7.
Neutel JM and Smith DHG (1998). Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv. Ther, 15: 206-217.
Prabhakara P, Ravi M, Marina K, Vijaynarayana K, Ullas D'Souza, Harish NM, Shastry CS and Charyulu RN (2011). Formulation and evaluation of fast dissolving films of levocitirizine dihydrochloride. International journal of pharmaceutical investigation, 1(2): 99-104.
Raghava Naidu S, Prasanna Raju Y, Rahul Nair, Omar Z. Ameer, Ibrahim M. Salman, Amirin S and MD Zaini A (2012). Chronic effects of Andrographis paniculata Chloroform Extract in Spontaneously hypertensive Rats. J. Pharm. Sci. & Res, 4(8): 1924-1928.
Ram Choudhary D, Vishnu P, Harsha P, and Aliasgar JK (2011). Formulation and evaluation of quick dissolving film of ondansetron hydrochloride. International Journal of Pharmaceutical Research, 3(4): 31-35.
Renuka M and Avani A (2011). Design and development of rapidly dissolving films using ion exchange resin for taste masking. International journal of drug formulation & research, 2(2): 314-34.
Shinde AJ, Garala KC, and More HN (2008). Development and characterization of transdermal therapeutics system of tramadol hydrochloride. Asian J. Pharm., 2(4): 265‐269.
Stangier J, Su CA, and Roth W (2000). Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J. Int. Med. Res, 28: 149-167.
Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, and Entzeroth M (1993). Pharmacological characterization of the novel non-peptide angiotensin II receptor antagonist. Br. J. Pharmacol, 110: 245-252.
Yoshifumi M, Takashi I, Kyoko KNN, and Ryosei K (2010). Preparation of Fast Dissolving Films for Oral Dosage from Natural Polysaccharides. Materials, 3: 4291-4299